Patent ID: 11952364
Assignee: TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 23:
24. The method of claim 17, wherein the diseases or disorders are selected from the group consisting of infantile fibrosarcoma carcinoma, lung adenocarcinoma, intrahepatic cholangiocarcinoma, colorectal cancer, papillary thyroid carcinoma, spitzoid neoplasm, glioblastoma, astrocytoma, head and neck cancer, low-grade glioma, secretory breast cancer, acute myeloid leukemia, congenital mesodermal nephroma, congenital fibrosarcoma, acute lymphoblastic leukemia, colorectal adenocarcinoma, thyroid carcinoma, cutaneous melanoma and pediatric glioma sarcoma.